Jasvinder A Singh1,2,3,4, Aseem Bharat2,3, Dinesh Khanna5, Cleopatra Aquino-Beaton6, Jay E Persselin6, Erin Duffy7, David Elashoff7, Puja P Khanna5,8. 1. Medicine Service, Birmingham VA Medical Center Jasvinder.md@gmail.com. 2. Department of Medicine, School of Medicine. 3. Division of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL. 4. Department of Orthopedic Surgery, Mayo Clinic College of Medicine, Rochester, MN. 5. Department of Medicine, University of Michigan, Ann Arbor, MI. 6. Department of Biostatistics, VA Greater Los Angeles Healthcare System. 7. Department of Medicine, University of California, Los Angeles, CA. 8. Department of Medicine, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA.
Abstract
OBJECTIVE: To compare the health-related quality of life (HRQOL) and the functional ability by race in patients with gout. METHODS: In a 9-month prospective cohort multicentre study, patients with gout self-reported race, dichotomized as Caucasian or African American (others excluded). We calculated HRQOL/function scores adjusted for age, study site and college education for Short Form-36 (SF-36; generic HRQOL), Gout Impact Scale (GIS; disease-specific HRQOL) and HAQ-disability index (HAQ-DI; functional ability). Longitudinally adjusted scores were computed using multivariable mixed-effect regression models with a random patient effect and fixed sequential visit effect (3-monthly visits). RESULTS: Compared with Caucasians (n = 107), African Americans (n = 60) with gout were younger (61.1 vs 67.3 years) and had higher median baseline serum urate (9.0 vs 7.9 mg/dl) (P < 0.01). African Americans with gout had worse HRQOL scores on three SF-36 domains, the mental component summary (MCS) and two of the five GIS scales than Caucasians [mean (se); P ⩽ 0.02 for all]: SF-36 mental health, 39.7 (1.1) vs 45.2 (0.9); SF-36 role emotional, 42.1 (4.2) vs 51.4 (4.2); SF-36 social functioning, 36.0 (1.1) vs 40.0 (0.9) (P = 0.04); SF-36 MCS, 43.2 (3.1) vs 50.0 (3.2); GIS unmet treatment need, 37.6 (1.6) vs 31.5 (1.4); and GIS concern during attacks, 53.3 (3.7) vs 47.4 (3.7). Differences between the respective HAQ-DI total scores were not statistically significant; 0.98 (0.1) vs 0.80 (1.0) (P = 0.11). Racial differences in SF-36 mental health, role emotional and MCS scales exceeded, and for HAQ-DI approached, the minimal clinically important difference thresholds. CONCLUSIONS: African Americans with gout have significantly worse HRQOL compared with Caucasians. Further research is necessary in the form of studies targeted at African Americans on how best to improve these outcomes. Published by Oxford University Press on behalf of the British Society for Rheumatology 2016. This work is written by US Government employees and is in the public domain in the US.
OBJECTIVE: To compare the health-related quality of life (HRQOL) and the functional ability by race in patients with gout. METHODS: In a 9-month prospective cohort multicentre study, patients with gout self-reported race, dichotomized as Caucasian or African American (others excluded). We calculated HRQOL/function scores adjusted for age, study site and college education for Short Form-36 (SF-36; generic HRQOL), Gout Impact Scale (GIS; disease-specific HRQOL) and HAQ-disability index (HAQ-DI; functional ability). Longitudinally adjusted scores were computed using multivariable mixed-effect regression models with a random patient effect and fixed sequential visit effect (3-monthly visits). RESULTS: Compared with Caucasians (n = 107), African Americans (n = 60) with gout were younger (61.1 vs 67.3 years) and had higher median baseline serum urate (9.0 vs 7.9 mg/dl) (P < 0.01). African Americans with gout had worse HRQOL scores on three SF-36 domains, the mental component summary (MCS) and two of the five GIS scales than Caucasians [mean (se); P ⩽ 0.02 for all]: SF-36 mental health, 39.7 (1.1) vs 45.2 (0.9); SF-36 role emotional, 42.1 (4.2) vs 51.4 (4.2); SF-36 social functioning, 36.0 (1.1) vs 40.0 (0.9) (P = 0.04); SF-36 MCS, 43.2 (3.1) vs 50.0 (3.2); GIS unmet treatment need, 37.6 (1.6) vs 31.5 (1.4); and GIS concern during attacks, 53.3 (3.7) vs 47.4 (3.7). Differences between the respective HAQ-DI total scores were not statistically significant; 0.98 (0.1) vs 0.80 (1.0) (P = 0.11). Racial differences in SF-36 mental health, role emotional and MCS scales exceeded, and for HAQ-DI approached, the minimal clinically important difference thresholds. CONCLUSIONS: African Americans with gout have significantly worse HRQOL compared with Caucasians. Further research is necessary in the form of studies targeted at African Americans on how best to improve these outcomes. Published by Oxford University Press on behalf of the British Society for Rheumatology 2016. This work is written by US Government employees and is in the public domain in the US.
Authors: Dinesh Khanna; John D Fitzgerald; Puja P Khanna; Sangmee Bae; Manjit K Singh; Tuhina Neogi; Michael H Pillinger; Joan Merill; Susan Lee; Shraddha Prakash; Marian Kaldas; Maneesh Gogia; Fernando Perez-Ruiz; Will Taylor; Frédéric Lioté; Hyon Choi; Jasvinder A Singh; Nicola Dalbeth; Sanford Kaplan; Vandana Niyyar; Danielle Jones; Steven A Yarows; Blake Roessler; Gail Kerr; Charles King; Gerald Levy; Daniel E Furst; N Lawrence Edwards; Brian Mandell; H Ralph Schumacher; Mark Robbins; Neil Wenger; Robert Terkeltaub Journal: Arthritis Care Res (Hoboken) Date: 2012-10 Impact factor: 4.794
Authors: Dinesh Khanna; Andrew J Sarkin; Puja P Khanna; Marian M Shieh; Arthur F Kavanaugh; Robert A Terkeltaub; Susan J Lee; Jasvinder A Singh; Jan D Hirsch Journal: Rheumatology (Oxford) Date: 2011-03-03 Impact factor: 7.580
Authors: Puja P Khanna; George Nuki; Thomas Bardin; Anne-Kathrin Tausche; Anna Forsythe; Amir Goren; Jeffrey Vietri; Dinesh Khanna Journal: Health Qual Life Outcomes Date: 2012-09-22 Impact factor: 3.186
Authors: Jan D Hirsch; Robert Terkeltaub; Dinesh Khanna; Jasvinder Singh; Andrew Sarkin; Micki Shieh; Arthur Kavanaugh; Susan J Lee Journal: Patient Relat Outcome Meas Date: 2010-03-01
Authors: Mara A McAdams-DeMarco; Janet W Maynard; Alan N Baer; Josef Coresh Journal: J Clin Hypertens (Greenwich) Date: 2012-06-13 Impact factor: 3.738
Authors: Natalie McCormick; Na Lu; Chio Yokose; Amit D Joshi; Shanshan Sheehy; Lynn Rosenberg; Erica T Warner; Nicola Dalbeth; Tony R Merriman; Kenneth G Saag; Yuqing Zhang; Hyon K Choi Journal: JAMA Netw Open Date: 2022-08-01
Authors: Erin Peacock; Cara Joyce; Leslie S Craig; Zachary Lenane; Elizabeth W Holt; Paul Muntner; Marie Krousel-Wood Journal: J Hypertens Date: 2021-01 Impact factor: 4.776